Literature DB >> 18521254

Gonadotrophin-releasing hormone (GnRH) analogues in the treatment of mixed mullerian tumours of the uterus: two case reports and review.

M Katesmark1, F Lawton.   

Abstract

Subjects/Discussion. Two cases of clinical and radiological response of recurrent mixed Mullerian tumours following treatment with either nasal (Buserilin) or intramuscular (Goserilin) GnRH analogues are reported and a short review of the evidence to support this treatment option presented.

Entities:  

Year:  1998        PMID： 18521254      PMCID： PMC2395392          DOI： 10.1080/13577149877975

Source DB:  PubMed          Journal:  Sarcoma        ISSN： 1357-714X


  14 in total

1.  Experience with hormonal therapy in advanced epithelial ovarian cancer.

Authors:  N van der Vange; S Greggi; C W Burger; P Kenemans; J B Vermorken
Journal:  Acta Oncol       Date:  1995       Impact factor: 4.089

2.  Uterine sarcomas: natural history, treatment and prognosis.

Authors:  O M Salazar; T A Bonfiglio; S F Patten; B E Keller; M Feldstein; M E Dunne; J Rudolph
Journal:  Cancer       Date:  1978-09       Impact factor: 6.860

3.  Uterine sarcoma: steroid receptors and response to hormonal therapy.

Authors:  K Wade; M A Quinn; I Hammond; K Williams; M Cauchi
Journal:  Gynecol Oncol       Date:  1990-12       Impact factor: 5.482

4.  [Prognostically relevant factors in malignant mixed Müllerian tumor].

Authors:  C Marth; A Koza; E Müller-Holzner; H Hetzel; L C Fuith; O Dapunt
Journal:  Geburtshilfe Frauenheilkd       Date:  1990-08       Impact factor: 2.915

5.  Prognostic factors for malignant mixed müllerian tumors of the uterus.

Authors:  W Schweizer; R Demopoulos; U Beller; N Dubin
Journal:  Int J Gynecol Pathol       Date:  1990       Impact factor: 2.762

6.  Carcinosarcoma of the uterus: a 40-year experience from the state of Missouri.

Authors:  L L Doss; A S Llorens; E M Henriquez
Journal:  Gynecol Oncol       Date:  1984-05       Impact factor: 5.482

7.  Uterine sarcomas: a clinicopathologic study.

Authors:  S Chiara; G Foglia; F Odicino; A Graziani; P F Conte; N Ragni; E Fulcheri; G Pescetto
Journal:  Oncology       Date:  1988       Impact factor: 2.935

8.  Effects of GnRH analogs on six ovarian cancer cell lines in culture.

Authors:  J P Connor; R E Buller; P M Conn
Journal:  Gynecol Oncol       Date:  1994-07       Impact factor: 5.482

9.  Evidence for tight coupling of gonadotropin-releasing hormone receptors to phosphatidylinositol kinase in plasma membrane from ovarian carcinomas.

Authors:  H Takagi; A Imai; T Furui; S Horibe; T Fuseya; T Tamaya
Journal:  Gynecol Oncol       Date:  1995-07       Impact factor: 5.482

10.  Retrospective analysis of 318 cases of uterine sarcoma.

Authors:  K S Oláh; H Gee; S Blunt; J A Dunn; K Kelly; K K Chan
Journal:  Eur J Cancer       Date:  1991       Impact factor: 9.162
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.